Browse
Browse and Search
Search
Explore more content
pwk_cp_reversibility.
pdf
(70.53 kB)
File info
This item contains files with download restrictions
Fullscreen
Reversibility of cysteine protease inhibition in the context of drug design
Cite
Download
(70.53 kB)
Share
Embed
preprint
posted on 2020-04-01, 17:58
authored by
Peter W Kenny
Peter W Kenny
Some notes on the relevance to drug design of the reversibility of cysteine protease inhibition.
History
Usage metrics
Categories
Biochemistry and cell biology not elsewhere classified
Bioinorganic chemistry
Biologically active molecules
Medicinal and biomolecular chemistry not elsewhere classified
Keywords
SARS-CoV-2 main protease
cysteine protease
inhibitor design
fragment-based design
FBLD
FBDD
reversibility
Biochemistry
Bioinorganic Chemistry
Biologically Active Molecules
Medicinal and Biomolecular Chemistry not elsewhere classified
Licence
CC BY 4.0
Exports
Select an option
RefWorks
RefWorks
BibTeX
BibTeX
Ref. manager
Ref. manager
Endnote
Endnote
DataCite
DataCite
NLM
NLM
DC
DC